Company intelligence / Profile preview

Peptide Institute

Minoh-shi, Osaka-fu, Japanpeptide.co.jp ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Peptide Institute is a leading Japanese company specializing in the synthesis, modification, and analysis of peptides and proteins. It offers both catalog products (~1000), custom peptide synthesis (>500 per year), R&D manufacturing, GMP production services, and has supported pharmaceutical research globally since 1977. The company’s own drug development activities are limited; its main pipeline asset was calciseptine for hypertension but this program is discontinued.

Therapeutic areas: Cardiovascular
Modalities: PeptidesProteinSmall molecule (for enzyme inhibitors/substrates and modifications)
Industry: Drug Discovery Services

Partnerships

OEM supplier to many peptide vendors globally

Beyond the preview

Go deeper on Peptide Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptide Institute.

Explore the full profile